Erythritol may impair cellular functions essential to maintaining brain blood vessel health, according to researchers at the ...

DelveInsight's "FILSPARI Market Size, Forecast, and Market Insight Report" highlights the details around FILSPARI, the first and only ...

F230, originally discovered by Eisai Co., Ltd. and exclusively licensed by GNI Group Ltd. to Gyre, is a fully synthetic small molecule designed to selectively block the ETA receptor. By targeting this ...

Gyre Therapeutics ("Gyre") (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across ...

The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

Among patients with pulmonary arterial hypertension treated with selexipag, the 10-year survival rate was 60%, according to ...

Unlike conventional heart medications that typically target one specific pathway, ferulic acid appears to work through ... histamine, serotonin, and endothelin-1. The team tested different ...

The present study demonstrates that chronic blockade of endothelin receptors is associated with an early and sustained increase of ischemia-induced angiogenesis in vivo and that this effect is ...

By addressing this shared pathway, interventions could mitigate neurovascular ... to mitigate neuroinflammation-induced astrocytic endothelin-1 overproduction, which disrupts capillary perfusion; (3) ...

Travere Therapeutics today announced that the Company will present three abstracts at the upcoming International Podocyte Conference.

The long pathway to cell organization and growth Date: May 15, 2025 Source: University of California - San Diego Summary: Sterols are among the most abundant lipids in eukaryotic cells, yet are ...